| Year | University | Degree |
|---|---|---|
| 2022 | University of Central Florida | Master of Research Administration |
(1) A Computer Lab consisting of six servers, including one with four NVIDIA V100 GPUs for machine learning and high performance computing. (2) A Biosafely Level 2 Biochemistry Lab, including CRISPR/Cas9 gene editing capabilities, for the in vitro investigation of the molecular mechanisms of cancer.
Investigating the role of clonal hematopoitic (CH) mutation (clonally expanded mutations in immune cells) on the genesis and progression of cancer. Using Machine Learning algorithms, we have developed a genomic screening panel (“liquid biopsy”) for lung cancer based on CH mutations. We are collaborating with VT Carilion Clinic to clinically validate this screening panel. Using CRISPR/Cas9 gene editing and cDNA clones we are also investigating the molecular mechanisms by which these CH mutations may affect anti-tumor immune function and tumor growth.
| Year | University | Degree |
|---|---|---|
| 2011 | Virginia Tech | PhD - Computer Science |
| 1979 | University of Maryland | MBA - Finance |
| 1977 | Indian Institute of Technology | BTech - Mechanical Engineering |
Sofia Abraham-Hardee, DO, PhD received her BS in Biology with a minor in Biochemistry from Bucknell University in Lewisburg, Pennsylvania. She completed a post-baccalaureate program at the Philadelphia College of Osteopathic Medicine. She received her Osteopathic medical degree from the Edward Via College of Osteopathic Medicine in 2007. She also completed her PhD in International Health Education from Virginia Tech in 2008. She completed her pediatric internship and residency at Geisinger Medical Center in Danville, Pennsylvania in June 2011. Dr. Abraham-Hardee is a board-certified pediatrician and is the Associate Dean for Clinical Affairs at Edward Via College of Osteopathic Medicine. She was awarded the Golden Apple Award 2014-2015. She was also awarded the 2013 Best Bedside Manner in Our Health Magazine.